DP, R., & A, R. (2017). Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy. Dove Medical Press.
Style de citation Chicago (17e éd.)DP, Roggeri, et Roggeri A. Economic Impact of the Use of Rifaximin 550 Mg Twice Daily for the Treatment of Overt Hepatic Encephalopathy in Italy. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)DP, Roggeri, et Roggeri A. Economic Impact of the Use of Rifaximin 550 Mg Twice Daily for the Treatment of Overt Hepatic Encephalopathy in Italy. Dove Medical Press, 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.